(Panel 1) High-Level Meeting on antimicrobial…

Guiding Questions:

• Question 1: How can we ensure equitable access to antimicrobials and other therapeutics,
  diagnostics and vaccines as required to prevent and treat drug-resistant infections in
  humans, animals and plants for improved health outcomes?
• Question 2: What are the most urgent actions needed to address AMR across human,
  animal, plant, and environmental sectors? Are there existing best practices that countries
  can adopt and scale up?
• Question 3: How can we ensure responsible and sustainable manufacturing, prudent use
  and disposal of antimicrobials for effective preventions across sectors?
• Question 4: How can we better raise awareness and educate communities for an effective
  behavioral change ensuring prevention and treatment of AMR in a multisectoral manner?
• Question 5: What innovative approaches, as well as high-impact and cost-effective preventive measures can be implemented to improve the national, regional and
  international AMR responses, particularly in low-resource settings?

The High-level Meeting on Antimicrobial Resistance is convened by the President of the General Assembly. Theme: Investing in the present and securing our future together: accelerating multisectoral global, regional and national actions to address antimicrobial resistance.

Drug-resistant infections know no borders, meaning no single country can respond to AMR alone. This meeting is an important opportunity for world leaders to collectively address the looming threat AMR poses to global health, food security, and achieving the 2030 Sustainable Development Goals.

The High-level Meeting will consist of an opening segment, a plenary, two interactive multi-stakeholder panels, and a closing segment.

The high-level meeting is expected to approve a concise and action-oriented political declaration with a shared vision including the consideration of measurable targets and objectives on mobilizing political will and action to address the drivers, sources and challenges of antimicrobial resistance, agreed in advance by consensus through intergovernmental negotiations, to be submitted by the President of the General Assembly for adoption by the Assembly.

In 2016 the first high-level meeting on AMR resulted in a political declaration that laid the foundation for global action against Antimicrobial Resistance (AMR).

According to the World Health Organization, AMR is one of the top global public health and development threats. It is estimated that bacterial AMR was directly responsible for 1.27 million global deaths in 2019.

The World Bank estimates that it could result in US$ 1 trillion additional healthcare costs by 2050, and up to US$ 3.4 trillion gross domestic product (GDP) losses per year by 2030.